Detection and Extraction of Heparin from Camel Lungs

Author:

Almeman Ahmad1,Abdulmajed Kasem2,Eid Eltayeb E.2

Affiliation:

1. Clinical Pharmacology and Therapeutic Department, Medicine Faculty, Qassim University, Almulaida, Saudi Arabia

2. Medical Sciences Department, Faculty Medicine Unyzah Campus, Qassim University, Unyzah, Saudi Arabia

Abstract

Background: Heparin is an essential drug used as an anticoagulant. Access to raw material suitable for heparin extraction is critical for creating a viable business opportunity. In Saudi Arabia, large amounts of raw material with potential for heparin extraction are wasted. Objective: To extract heparin and low-molecular-weight heparin (LMWH) from the camel lung, and measure its potency and activity. Methods: Heparin preparation included three steps: extraction, electrophoretic identification, and activity measurement. Fresh lung tissue (100 g) was minced and homogenized in a blender. Crude heparin extracts were prepared using Charles’s or Volpi’s method with slight modifications. Heparin was purified by electrophoresis using high-purity agarose gels in barium acetate buffer. The heparin activity of purified samples was assayed spectrophotometrically using commercial heparin kits. Results: Charles’s and Volpi’s extraction methods were simple and easy to establish. The yield was 90 mg crude heparin per 100 g of camel lung tissue following Volpi’s extraction protocol, whereas Charles’s method did not yield any heparin. The separation of heparin and LMWH by gel electrophoresis resulted in sharp and clear product bands using material prepared according to Volpi’s method. The heparin preparation had an anti-factor Xa activity of 37 IU/mg, indicating weak potency. Conclusion: Preparation of active heparin from camel lung tissue is a technology applicable in manufacturing. Further method development is needed to increase heparin purity and potency.

Funder

Qassim University, Deanship for Scientific Research, Saudi Arabia

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Reference29 articles.

1. . , WHO Model List of Essential Medicines (19th List). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016,, , ,, -,

2. Hylek EM, Regan S, Henault LE, Gardner M, Chan AT, Singer DE, Barry MJ. Arch Intern Med, Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis.,, 2003, 163,, 621-627,

3. Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, McBane RD, Moll S, Ansell J. J Thromb, Guidance for the treatment of deep vein thrombosis and pulmonary embolism.,, 2016, 41,, 32-67,

4. Li JJ, Corey EJ. Drug discovery: Practices, Processes, and Perspectives, ,, 2013, 41,, 32-,

5. . Drug discovery: Practices, Processes, and Perspectives, ,, , 41,, 32-,United States Food and Drug Administration (2010) Generic enoxaparin questions and answers. Accessed 15 Jan 2019.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3